218 related articles for article (PubMed ID: 22341307)
1. Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer.
Jamal B; Sengupta PK; Gao ZN; Nita-Lazar M; Amin B; Jalisi S; Bouchie MP; Kukuruzinska MA
Oral Oncol; 2012 Jun; 48(6):523-9. PubMed ID: 22341307
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.
Liu G; Sengupta PK; Jamal B; Yang HY; Bouchie MP; Lindner V; Varelas X; Kukuruzinska MA
J Biol Chem; 2013 Jul; 288(28):20217-27. PubMed ID: 23703614
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation of N-glycosylation gene DPAGT1, canonical Wnt signaling and E-cadherin adhesion.
Sengupta PK; Bouchie MP; Nita-Lazar M; Yang HY; Kukuruzinska MA
J Cell Sci; 2013 Jan; 126(Pt 2):484-96. PubMed ID: 23178939
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer.
Nita-Lazar M; Noonan V; Rebustini I; Walker J; Menko AS; Kukuruzinska MA
Cancer Res; 2009 Jul; 69(14):5673-80. PubMed ID: 19549906
[TBL] [Abstract][Full Text] [Related]
5. N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.
Sengupta PK; Bouchie MP; Kukuruzinska MA
J Biol Chem; 2010 Oct; 285(41):31164-73. PubMed ID: 20693288
[TBL] [Abstract][Full Text] [Related]
6. Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling.
Varelas X; Bouchie MP; Kukuruzinska MA
Glycobiology; 2014 Jul; 24(7):579-91. PubMed ID: 24742667
[TBL] [Abstract][Full Text] [Related]
7. The Integrated Role of Wnt/β-Catenin, N-Glycosylation, and E-Cadherin-Mediated Adhesion in Network Dynamics.
Vargas DA; Sun M; Sadykov K; Kukuruzinska MA; Zaman MH
PLoS Comput Biol; 2016 Jul; 12(7):e1005007. PubMed ID: 27427963
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
9. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma.
Sogabe Y; Suzuki H; Toyota M; Ogi K; Imai T; Nojima M; Sasaki Y; Hiratsuka H; Tokino T
Int J Oncol; 2008 Jun; 32(6):1253-61. PubMed ID: 18497987
[TBL] [Abstract][Full Text] [Related]
11. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
12. Canonical Wnt pathway gene expression and their clinical correlation in oral squamous cell carcinoma.
Marimuthu M; Andiappan M; Wahab A; Muthusekhar MR; Balakrishnan A; Shanmugam S
Indian J Dent Res; 2018; 29(3):291-297. PubMed ID: 29900911
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.
Katase N; Lefeuvre M; Tsujigiwa H; Fujii M; Ito S; Tamamura R; Buery RR; Gunduz M; Nagatsuka H
Oncol Rep; 2013 Apr; 29(4):1349-55. PubMed ID: 23354949
[TBL] [Abstract][Full Text] [Related]
14. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
15. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.
Zhang WM; Lo Muzio L; Rubini C; Yan G
Oncol Rep; 2005 Jun; 13(6):1095-9. PubMed ID: 15870927
[TBL] [Abstract][Full Text] [Related]
16. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
Pannone G; Bufo P; Santoro A; Franco R; Aquino G; Longo F; Botti G; Serpico R; Cafarelli B; Abbruzzese A; Caraglia M; Papagerakis S; Lo Muzio L
Oncol Rep; 2010 Oct; 24(4):1035-41. PubMed ID: 20811686
[TBL] [Abstract][Full Text] [Related]
17. The anti-apoptotic PON2 protein is Wnt/β-catenin-regulated and correlates with radiotherapy resistance in OSCC patients.
Krüger M; Amort J; Wilgenbus P; Helmstädter JP; Grechowa I; Ebert J; Tenzer S; Moergel M; Witte I; Horke S
Oncotarget; 2016 Aug; 7(32):51082-51095. PubMed ID: 27322774
[TBL] [Abstract][Full Text] [Related]
18. Dickkopf-1 inhibits thyroid cancer cell survival and migration through regulation of β-catenin/E-cadherin signaling.
Cho SW; Lee EJ; Kim H; Kim SH; Ahn HY; Kim YA; Yi KH; Park DJ; Shin CS; Ahn SH; Cho BY; Park YJ
Mol Cell Endocrinol; 2013 Feb; 366(1):90-8. PubMed ID: 23261982
[TBL] [Abstract][Full Text] [Related]
19. Slit-2 facilitates interaction of P-cadherin with Robo-3 and inhibits cell migration in an oral squamous cell carcinoma cell line.
Bauer K; Dowejko A; Bosserhoff AK; Reichert TE; Bauer R
Carcinogenesis; 2011 Jun; 32(6):935-43. PubMed ID: 21459757
[TBL] [Abstract][Full Text] [Related]
20. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
